As the underlying mechanism, we found PRP19 knockdown in HCC cells inhibited DDX5 protein degradation, thus promoting CXCL12 expression to induce B cell recruitment via binding the receptor CXCR4. Here, PRPF19 is linked to hepatocellular carcinoma.